EP300 and B-cell non-Hodgkin lymphoma: Previously, mutations in the region regulating the histone acetyltransferase activity of p300 have been reported in small cell lung cancer and B-cell lymphoma patients, [9], [10] but these studies did not report any association between the mutations and the patient survival.